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Abstract
Mycolactone A/B is a lipophilic macrocyclic polyketide that is the primary virulence factor produced by Mycobacterium
ulcerans, a human pathogen and the causative agent of Buruli ulcer. In M. ulcerans strain Agy99 the mycolactone polyketide
synthase (PKS) locus spans a 120 kb region of a 174 kb megaplasmid. Here we have identified promoter regions of this PKS
locus using GFP reporter assays, in silico analysis, primer extension, and site-directed mutagenesis. Transcription of the large
PKS genes mlsA1 (51 kb), mlsA2 (7 kb) and mlsB (42 kb) is driven by a novel and powerful SigA-like promoter sequence
situated 533 bp upstream of both the mlsA1 and mlsB initiation codons, which is also functional in Escherichia coli,
Mycobacterium smegmatis and Mycobacterium marinum. Promoter regions were also identified upstream of the putative
mycolactone accessory genes mup045 and mup053. We transformed M. ulcerans with a GFP-reporter plasmid under the
control of the mls promoter to produce a highly green-fluorescent bacterium. The strain remained virulent, producing both
GFP and mycolactone and causing ulcerative disease in mice. Mosquitoes have been proposed as a potential vector of M.
ulcerans so we utilized M. ulcerans-GFP in microcosm feeding experiments with captured mosquito larvae. M. ulcerans-GFP
accumulated within the mouth and midgut of the insect over four instars, whereas the closely related, non-mycolactone-
producing species M. marinum harbouring the same GFP reporter system did not. This is the first report to identify M.
ulcerans toxin gene promoters, and we have used our findings to develop M. ulcerans-GFP, a strain in which fluorescence
and toxin gene expression are linked, thus providing a tool for studying Buruli ulcer pathogenesis and potential
transmission to humans.
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Introduction
Mycobacterium ulcerans is the causative agent of Buruli ulcer (BU)
an emerging but neglected disease found predominantly in tropical
regions of the world and with an increasing incidence in West and
Central Africa [1,2]. BU is a chronic infection of subcutaneous
tissue that can result in high morbidity such as permanent scarring
and functional disabilities. The combination of rifampin and an
aminoglycoside for four to eight weeks leads to the healing of early
lesions without radical surgery and is now the recommended
standard regimen [3]. However, substantial tissue damage often
necessitates surgery [4]. The social and economic burden of BU
can be severe, particularly in impoverished rural regions of West
Africa where the prevalence of BU is sometimes higher than that
of the two most significant mycobacterial diseases, leprosy and
tuberculosis. Cases of BU are usually clustered around swamps
and slow-flowing water and while the mode of transmission of M.
ulcerans is unknown, evidence to date suggests, fish [5], snails [6]
and certain carnivorous aquatic insects [7,8] can all harbour the
bacterium. Recent studies in Australia suggest mosquitoes may
play a role in transmission [9,10].
A major factor influencing the pathology of Buruli ulcer is
the production by M. ulcerans of a secondary metabolite called
mycolactone [11]. Mycolactone is an immunosuppressive and
cytotoxic macrocyclic polyketide, characterised by a 12-membered
macrolactone core appended to a highly unsaturated acyl side
chain [11,12]. Polyketides are a class of naturally occurring
compounds, some of which have potent pharmaceutical activity
such as the immune suppressor rapamycin, the antibiotic
erythromycin A, and the antiparasitic agent avermectin [13–15].
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studies on the effect of the molecule in cell culture and animal
models have shown that in the microgram range it has cytotoxic
properties, while at sub-cytotoxic concentrations it has immuno-
modulatory properties, most strikingly the inhibition of tumour
necrosis factor production by monocytes and macrophages
[16–18]. In mice, mycolactone has been shown to concentrate
within peripheral blood monocytes [19].
Mycolactone synthesis is dependent on the pMUM megaplas-
mid found in M. ulcerans and closely related mycobacteria (Figure 1)
[20–23]. This plasmid contains three, very large genes (mlsA1:
51 kb, mlsA2: 7 kb, and mlsB: 42 kb) that encode type I polyketide
synthases (PKS). MlsA1 and MlsA2 synthesize the upper side
chain and macrolactone core, whilst MlsB synthesizes the acyl side
chain [22]. A putative beta-ketoacyl transferase encoded by
another pMUM gene, mup045, is thought to catalyse the ester
linkage between the acyl side chain and the macrolactone core
whilst a P450 hydroxylase, encoded by mup053, oxidizes the side
chain at C129 (Figure 1) [22–25]. A third gene, mup038, is
predicted to encode a type II thioesterase that might be required
for removing aberrant polyketide extension products from the Mls
PKS that form during synthesis. An unusual feature of the
mycolactone PKS is the very high level of sequence identity
between domains of the same function (98.7–100% nt identity and
98.3–100% aa identity). This observation suggested that the
evolution of the locus may be recent and also prone to
rearrangements that result in either loss of mycolactone produc-
tion or production of new mycolactones. These hypotheses have
recently gained support by studies that have shown (i) all
mycolactone producing mycobacteria (which includes M. ulcerans
and some closely related fish and frog pathogens) have recently
evolved from a common Mycobacterium marinum ancestor by pMUM
plasmid acquisition [23–28], (ii) laboratory passaging leads to
mycolactone negative mutants through spontaneous deletion of mls
gene fragments [29], and (iii) natural swapping of particular
acyltransferase and ketoreductase domains and loss or gain of
entire extension modules in some strains of M. ulcerans has led to
the production of new mycolactones [30,31].
However, there have been very few studies of gene expression in
M. ulcerans. Therefore, in this study we began by investigation of
the mycolactone-associated genes mlsA1/mlsA2, mlsB, mup045,
mup053 and mup038. Promoter regions were mapped upstream
of the above genes using a GFP reporter. Putative transcriptional
start sites and promoter sequences were then identified by primer
extension analysis and site-directed mutagenesis. The GFP
reporter containing the promoter region of the mls genes was
then used to transform M. ulcerans. This recombinant GFP
M. ulcerans fluoresced brightly and was used to follow infection in
both mice and mosquito larvae.
Materials and Methods
Bacterial strains and culture conditions
The bacterial strains and plasmids used in this study are
described in Table S1. All cloning experiments were performed in
Escherichia coli DH10B, cultivated in Luria-Bertani (LB) broth at
37uC or on LB agar containing 50 mg kanamycin, for 16 hours at
37uC. Mycobacterial strains were grown in Middlebrook 7H9
medium (Difco) supplemented with albumin (6.25% (w/v)),
dextrose (2.5% (w/v)), sodium chloride (1.1% (w/v)), catalase
(5610
24% (w/v)) and 0.05% (v/v) Tween280 at 37uC for
Mycobacterium smegmatis and 30uC for M. marinum and M. ulcerans.
Mycobacteria were also cultured on 7H10 agar supplemented with
OADC (Difco). Recombinant mycobacteria were cultivated with
kanamycin at a final concentration of 25 mgm l
21.
DNA methods
Standard methods were used for cloning, PCR and DNA
sequencing. The oligonucleotides used in this study for PCR, RT-
PCR and DNA sequencing are listed in Table S2. Genomic DNA
was extracted from mycobacteria as described [23]. The broad
host range, promoterless, GFP (gfpmut3) vector pSM20, that
replicates in E. coli, Corynebacterium sp. and Mycobacterium sp, was
used for all promoter cloning experiments [32]. PCR products
Figure 1. Schematic representation of the M. ulcerans Agy99
megaplasmid pMUM001, and the promoterless GFP vector
pSM20. The regions upstream of key genes involved in mycolactone
biosynthesis cloned into pSM20 and the names of the resulting plasmid
GFP-reporter constructs are indicated. The 8.4 kb duplicated region that
spans the load modules of mlsA1 and mlsB and 1.6 kb upstream of each
gene is circled. E=EcoRV, B=BamHI, S=SphI, ‘*’ indicates that this
single construct represents the encircled duplicated regions upstream
of mlsA1 and mlsB.
doi:10.1371/journal.pntd.0000553.g001
Author Summary
Buruli ulcer (BU) is a serious skin infection of humans
predominantly occurring in West and Central Africa. The
disease is caused by infection with Mycobacterium
ulcerans, a bacterium that produces an unusual toxin
called mycolactone. There are many unanswered ques-
tions surrounding BU, particularly regarding the role of
mycolactone in disease and how M. ulcerans is transmitted
to humans. Here, we have partly addressed these
questions by identifying genetic factors controlling the
transcription of the mycolactone genes. Using a variety of
experimental approaches, including green fluorescent
protein (GFP) as a reporter of gene expression, we have
identified strong promoters that drive transcription of the
mycolactone genes in M. ulcerans. We then used our GFP
reporters to produce highly fluorescent M. ulcerans-GFP
that were readily visualized by microscopy. Mosquitoes
have been proposed as a potential vector of M. ulcerans so
we used M. ulcerans-GFP in feeding experiments with
mosquito larvae. M. ulcerans-GFP accumulated within the
insects, whereas other mycobacteria did not. This is the
first report of the mycolactone gene promoters, and we
have used our findings to develop M. ulcerans-GFP, a strain
in which fluorescence and toxin gene expression are
linked, thus providing a powerful tool for studying Buruli
ulcer.
Gene expression of the mycolactone locus
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cleotides described in Table S2 and ligated into the unique
restriction enzyme sites immediately upstream of the gfp gene in
pSM20 (Figure 1). Constructs were confirmed to be correct by
DNA sequencing and then transformed into M. smegmatis mc
2155
as described [33]. Electrocompetent M. marinum and M. ulcerans
were prepared as described [34] and these cells were transformed
with 10 mg of DNA from plasmid pJKD2893 (Table S1). The
constructs were confirmed to be correct in mycobacteria by
Southern hybridization and back transformation to E. coli.
Acetone soluble lipids were extracted from recombinant M.
ulcerans and analysed by LC-MS for the presence of mycolactones
as previously described [35].
Measurement of green fluorescence protein (GFP)
expression
GFP expression in pSM20 and derivatives (Table S1) was
measured using a FLUOstar OPTIMA plate scanner (BMG Lab
Technologies). M. smegmatis strains were grown to an OD of 1.0
using a WPA CO8000 cell density meter (Isogen Life Science). For
each strain, 30 ml of starter culture was added to each of 16 wells
of a 96-well flat-bottomed clear plate containing 150 ml of fresh
7H9 medium. Plates were incubated at 37uC for 30 mins. Each
well was scanned using an excitation filter of 485 nm and an
emission filter of 520 nm. Fluorescence readings were taken every
10 minutes and the average of 20 flashes per well was taken to be
the measure of fluorescence. Prior to each reading, the plates were
shaken for 5 minutes in an orbital motion. Replicates were
averaged for each experiment and the average value for the
vector-only control was taken as background and subtracted from
the average at each time point.
Preparation of total RNA
Total RNA was prepared from E. coli using the RNeasy mini kit
as described and per the manufacturer’s instructions (Qiagen) [36].
For M. ulcerans, a 0.5 volume of RNAlater (Qiagen) was added to
100 ml of late log-phase culture and allowed to stand at room
temperature for 10 minutes prior to centrifugation at 4,600 g, for
10 minutes. The resultant cell pellet was washed in 1 ml of 0.5%
(v/v) Tween-80 per 50 mg of cells (wet weight), resuspended in
800 ml of RNA lysis buffer (0.12 M sodium acetate (pH 4.0), 9.6%
(v/v) liquid Pyroneg (Diversey), pH 4.0) and then added to 250 mg
of glass beads (Sigma Aldrich), with 600 ml of acidified phenol:
chloroform (pH 4.0) (Sigma Aldrich). Cells were disrupted with a
FastPrep tissue homogenizer (Savant Instruments) for 45 seconds,
at speed 6 and chilled on ice for 5 minutes. The aqueous phase was
then re-extracted with chloroform:isoamylalcohol (24:1) and
precipitated with isopropanol, and 3 M sodium acetate (pH 4.6).
Two 70% (v/v) ethanol washes were performed and the pellet was
dried briefly under vacuum and resuspended in 100 ml of DEPC
water. RNA in this preparation was then further purified using an
RNeasy extraction kit, including an on-column DNase treatment,
following the manufacturers recommendations (Qiagen). For RNA
extraction from M. smegmatis and M. marinum the following
modifications to the above method were used. The cell pellet
was first resuspended in 2 ml of lysis solution (20 mM potassium
acetate (pH 4.8), 1 mM EDTA, 0.5% (v/v) SDS, 100 mg
proteinase K ml
21). One millilitre was added to 250 mg of glass
beads with 700 ml acidified phenol:chloroform pH 4.0. Cells were
disrupted by three cycles in a FastPrep instrument at speed 5, for
30 seconds, and then centrifuged at 17,900 g for 10 minutes. The
aqueous phase was recovered and extracted once with 500 ml
phenol:chloroform (pH 4.0) followed by a chloroform only
extraction. Nucleic acids were precipitated as above and RNA
extraction proceeded as for M. ulcerans using the RNeasy
extraction kit.
Primer extension
The primer extension protocol used was modified from Lloyd
et al., [37]. Two reverse transcription reactions were performed.
To the RNA-primer mix, 6 ml of 5x first strand buffer (Invitrogen),
15 mM DTT (Invitrogen), 1 mM dNTPs (Promega), 1 U RNasin
(Promega) and 100 U of Superscript II RNase H
- reverse
transcriptase (Invitrogen) were added. After one hour at 42uC,
2 ml of 5x first strand buffer, 1.5 mM dNTPs, 1 U RNasin,
15 mM DTT and 100 U of Superscript II was added and
incubated for a further hour at 42uC. Ten nanograms of RNaseA
(Sigma) was then added and allowed to incubate at 37uC for
30 minutes. The resultant cDNA was precipitated and washed
once with 70% (v/v) ethanol, dried and stored at 220uC until
analysis. Capillary electrophoresis was performed on an Applied
Biosystems 3730 DNA analyzer using Liz
TM 500 size standards to
generate a standard curve (Applied Biosystems). GenemapperH
version 3.7 (Applied Biosystems) was used to analyze the sample
files with automated allele calling verified by manual inspection.
The sized cDNA fragments were then mapped to their respective
first strand synthesis primer binding sites to identify the putative
transcription start site.
Bioinformatic analysis
From the alignment of each of the SigA, C, D, E, F, H & L
promoters [38], nucleotide frequency counts were derived and
used to construct a library of 110 position specific scoring matrices
(PSSMs) for each sigma factor (PSSMs available upon request).
This allowed the gap between the -35 and -10 signals to vary
between 14 and 23 residues, and the gap between the -10 signal
and the TSP to vary between 3 and 13 residues. PoSSuM software
[39] was used to scan the pMUM001 genome for high scoring hits
to these PSSM libraries [40], using a background model consistent
with the G+C biased nucleotide distribution of pMUM001. A
p-value significance cutoff of 0.0001 was used.
Site-directed mutagenesis
Splice overlap extension PCR [41] was used to alter the sequence of
putative promoter motifs with oligonucleotides1075-F and 1074-R for
mlsA1/mlsB,1667-F and 1668-R for mup045,and 1669-F and 1670-R
for mup053 (Table S2). Each PCR reaction consisted of 20 cycles of
94uC for 1 minute, 50uC for 1 minute and 72uC for 3 minutes then
94uC for 1 minute, 72uC for 10 minutes and held at 4uC. Two
overlapping PCR products were obtained and 2 ml( ,50 ng DNA) of
each were used in a subsequent reaction using the outermost primers
for each product to yield a complete fragment incorporating both
products. Each product was then ligated into pSM20 as described
above. Mutations were confirmed by DNA sequencing.
Mouse-tail infections
Ten, six-week-old female BALB/c mice (Charles River France,
http://www.criver.com/) were injected subcutaneously into the
tail with 30 ml of a suspension containing 5610
4 bacteria. To
favour the growth of the GFP-expressing bacilli, animals received
0.1 ml of a solution containing 80 mg/ml of kanamycin (1% w/v),
administered by oral gavage every day. The mice were killed and
their tails were collected fifty days after inoculation.
Ethics statement
Mice were maintained in the animal house facility of the Centre
Hospitalier Universitaire, Angers, France (Animal Ethics Committee,
Gene expression of the mycolactone locus
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to the institution’s guidelines for animal husbandry.
Detection of cultivable bacilli and histology
The tissue specimens from mice were minced with disposable
scalpels in a Petri dish and ground with a Potter–Elvehjem
homogeniser, size 22, (Kimble/Kontes, Vineland, NJ), in 0.15 M
NaCl to obtain a tenfold dilution. The suspension was decontam-
inated to remove other bacteria using an equal volume of N-acetyl-
L-cysteine sodium hydroxide (2%) [42] and inoculated on 7H10
agar supplemented with OADC (Difco), containing 25 mg/ml of
kanamycin. For histological examination, tissues were fixed in 4%
paraformaldehyde in phosphate buffer (pH 7.4). Decalcification of
the tissue was performed for 7 days in 0.1 M of EDTA solution in
PBS. Samples were frozen in isopentane cooled to 2140uCi n
liquid nitrogen and stored at 280uC for subsequent histochemical
analysis. Eight-micron thick transverse sections were cut at 230uC
on a cryostat (Jung-Reichert Cryocut 1800, Cambridge Instru-
ments, Germany) and kept at 280uC until histochemical
processing, which was done within 1 week of sectioning. For
detection of GFP-expressing bacilli, tissues were counterstained
with DAPI, with endogenous phosphatase activity first detected
using alkaline phosphatase substrate kit I (Vector Laboratories).
The preparation was then mounted in Vectashield mounting
medium containing DAPI (Vector Laboratories) and the samples
were visualized using fluorescence microscopy (Leica DM5000B).
Hematoxylin phloxine saffron and Ziehl Nielsen staining were
performed according to standard procedures.
Mosquito microcosm M. ulcerans-GFP feeding
experiments
Mosquito larvae (Aedes camptorhynchus) between first and second
instar were distributed into 4650 ml plastic tubes (10 larvae per
tube), containing 20 ml of sterile tap water. To three groups of
four tubes were added 1.5 ml of an aqueous slurry of possum
faecal material containing either 5610
6 colony forming units (cfu)
M. ulcerans-GFP, 5610
6 cfu M. marinum-GFP, or possum faecal
material alone. The larvae were left to feed on the material for one
week at 24uC. At the end of one week and also at the end of every
subsequent week up to week five, all larvae were transferred to new
tubes containing 20 ml of sterilized tap water. The original tubes
spiked with possum faecal material were kept at room temperature
and at the commencement of each week 500 ml of water from each
of these tubes was tested by IS2404 and ppk qPCR to estimate the
residual quantity in the water of M. ulcerans and M. marinum
respectively [43]. Results were reported as cfu by reference to
standard curves for each PCR and bacterial species, correlating
qPCR Ct values with cfu [43]. From weeks 2–5 the larvae were
sustained with small quantities of fish food added to each tube. A
larva was taken from each tube as it progressed through each
instar and tested by IS2404 PCR for the presence of M. ulcerans as
described [43]. A selection of 4
th instar larvae were also fixed
overnight in 10% formaldehyde in PBS (v/v) then mounted in
cedarwood oil (Matheson, Coleman and Bell) on a glass slide for
examination by fluorescence microscopy with an Olympus BX51
microscope (Olympus, Tokyo, Japan) with the following filter sets:
DAPI (Blue) ex: 360–70 nm, em: 420–60 nm, FITC (Green) ex:
450–80 nm, em: 535 nm, TRITC (red) ex: 535 nm, em: 635 nm.
Images were acquired using an Olympus DP-70 digital camera
and merged using DP controller software (version 1.1.1.71) or
Adobe Photoshop (version 8) These experiments were terminated
before the insects progressed to pupal and adult developmental
stages.
Results
Identification of promoter regions in mycolactone-
associated genes using a GFP-reporter
By cloning DNA fragments ranging from 229 bp–1646 bp
located immediately upstream of mlsA1/mlsB (these genes have a
duplicated start and upstream sequence so one cloned fragment
was sufficient to analyse both genes), mlsA2, mup038, mup045 and
mup053 in the promoterless GFP E. coli/Mycobacterium reporter
vector pSM20 (Table S1, Figure 1) we were able to discover
regions containing promoter activities. The resulting plasmids
were used to transform E. coli, M. smegmatis and, for the mlsA1/mlsB
construct, M. marinum and M. ulcerans were also transformed.
Bacteria were cultured in 96-well plates for 2 hours at 37uC and
expression of GFP for each strain was assessed by continuous
fluorescence measurements. E. coli expressing GFP from the
strong, constitutive promoter srp (pSM22) [32] and M. smegmatis
expressing GFP from the sigA promoter from Mycobacterium bovis
BCG (pJKD3042) [44] were used as positive controls for each
genus. Results were expressed as fold changes in fluorescence
above the levels detected in bacteria containing the empty vector
pSM20. The results for mlsA1 and mlsB are summarized in Figure 2
and show that strains containing the construct pJKD2893 with the
region 1646 bp upstream of mlsA1/mlsB, led to detectable GFP
expression in E. coli, and high levels of GFP expression in M.
smegmatis and M. marinum (Figure 2A). A single copy version of
pJKD2893 was also created where a DNA fragment spanning the
1646 bp mls upstream region and gfp gene from pJKD2893 was
subcloned into the mycobacterial integrating shuttle vector,
pJKD8003 resulting in pJKD3111. M. marinum transformed with
pJKD3111 expressed GFP 40-fold less than the same strain
containing pJKD2893 (Figure 2A).
To further localize the region conferring promoter activity within
the1646 bpupstream ofmlsA1/mlsB, fouroverlappingsub-clones of
this region were prepared by PCR, cloned into pSM20 and used to
transformE.coliandM.smegmatis.ComparisonofGFPexpression in
these constructs in another time course experiment, comparing
fluorescence with the full-length 1646 bp fragment and controls,
clearly showed that promoter activity was restricted to a 413 bp
fragment located between nucleotide positions 35996-36409 for
mlsA1 and 100821-101234 for mlsB in pMUM001 (Figure 2B).
The region 1440 bp upstream of mup045 and 1466 bp
upstream of mup053 also led to significant GFP expression in
M. smegmatis, 8–15 fold above background, but these regions
showed little transcriptional activity in E. coli (Figure S1). No
fluorescence was observed in either E. coli or M. smegmatis for
strains containing the 229 bp region upstream of mup038
(pJKD3269) or the 1096 bp region upstream of mlsA2 (pJKD3041)
(data not shown). These experiments demonstrate that the regions
upstream from mlsA1/mlsB, mup045 and mup053 all harbour at
least one strong promoter.
Identification of transcriptional start points (TSPs) for
mlsA1/mlsB, mup045, and mup053
To identify TSPs upstream of each gene primer extension (PE)
analysis was performed using RNA extracted from M. ulcerans
Agy99. For mlsA1/mlsB, RNA was also extracted from M. marinum
harbouring the GFP expression construct pJKD2893. One or
more 59 6-FAM-labeled antisense oligonucleotides were used to
prime cDNA synthesis to determine the TSP for mlsA1/mlsB,
mup045, and mup053 (Table S2). Single, distinct PE products
were identified for all three regions using multiple RNA
preparations (Figure S2, Figure S3). Size fragment analysis of
the PE products suggested single TSPs at 533 bp (T533) upstream
Gene expression of the mycolactone locus
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of mup045 (T207), and 68 bp upstream of mup053 (T068) (Figure
S3). Primer extension analysis of mup038 and mlsA2 was not
attempted due to the lack of promoter activity observed with the
wild type sequences in the GFP reporter assays.
Localization of putative promoter sequences by in silico
analysis
Several studies of promoters in mycobacteria facilitated the
construction of position-specific scoring matrices (PSSMs) to
perform in silico searches for potential regulatory regions in DNA
sequences [38]. We used sigma factor-specific libraries of PSSMs
to scan the regions upstream of the three TSPs identified by our
PE analysis. High-probability SigA-like promoter motifs were
predicted in the regions upstream of mlsA1/mlsB and mup045 and
a SigD-like motif was predicted upstream of mup053 (Table 1).
Confirmation of putative promoter elements by site-
directed mutagenesis
To confirm the in silico promoter predictions, the GFP
expression constructs spanning the putative -10 sequences from
mlsA1/mlsB (pJKD2893), mup045 (pJKD3040) and mup053
(pJKD3039) were mutated by PCR (Table 1). GFP production
by E. coli and M. smegmatis harbouring these constructs was assayed
as before by continuous fluorescence measurements over 2 hours
at 37uC. Fluorescence production was compared with the same
strains containing the wild-type putative promoter sequences.
Mutation of the proposed 210 boxes for both the mlsA1/mlsB and
mup045 reduced fluorescence in M. smegmatis to less than 4% of
the wild-type sequences, strongly suggesting these sequences are
functional 210 motifs, required for proper binding of the sigma
factor and RNA polymerase to initiate transcription (Figure 2B).
Mutation of the proposed 210 box from mup053 had no impact
on GFP expression.
Construction and analysis of M. ulcerans expressing GFP
under the control of the mlsA1/mlsB promoter
The strength of the mls promoter led us to develop a
GFP-producing strain of M. ulcerans that might be useful in studies
of pathogenesis or transmission. We transformed M. ulcerans
JKD8049 with plasmid pJKD2893, resulting in highly green
fluorescent M. ulcerans (JKD8083 or M. ulcerans-GFP), with
Figure 2. Summary of fluorescence data demonstrating the difference in promoter activity among strains containing GFP reporter
constructs. Shown are plasmid constructs with upstream regions from M. ulcerans mlsA1/mlsB (A) & (B). Also shown are the sigA promoter from M.
bovis BCG (construct pJKD3042) (B) and the srp promoter from E. coli (construct pSM22) (B). Point mutations in putative promoter regions in the
putative -10 motifs of promoter regions for mls sequences are marked by ‘X’. All values are expressed as fold changes above the strain containing the
empty vector pSM20. Strains are identifiable by a two-letter prefix to the strain number EC - E. coli, MS - M. smegmatis, MM - M. marinum and MU -
M. ulcerans.‘ *’ indicates this fluorescence is more than 100-fold higher than vector alone.
doi:10.1371/journal.pntd.0000553.g002
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(Figure 2A). To ensure that GFP expression did not stop
mycolactone production we performed cell LC-MS analysis of
acetone-soluble lipids from cultures of JKD8083 and confirmed
the presence of mycolactone A/B and C (Figure S4).
M. ulcerans-GFP retains virulence in vivo
Mouse-tail infection is a well-established animal model for
studying M. ulcerans. Forty days after subcutaneous inoculation of
10
5 M. ulcerans-GFP oedema was observed and on the 50
th day the
lesion became ulcerated and the mice were killed. Histological
study of the ulcerated region showed an area of necrosis consistent
with wild type M. ulcerans infection (Figure 3A, Figure 3B).
Granulomatous inflammation was not observed. Acid-fast bacilli
were localized in clumps in necrotic areas (Figure 3C) and
expressed green fluorescent protein (Figure 3D). The viability of
these bacteria was demonstrated by re-isolating them in bacterial
culture media. These results demonstrate that M. ulcerans-GFP is
virulent in the mouse model and provokes lesions typical of M.
ulcerans infection.
M. ulcerans-GFP accumulates within mosquito larvae
Adult mosquitoes in some Buruli ulcer endemic regions of
Australia have tested PCR positive for M. ulcerans and epidemi-
ological evidence suggests a role for biting insects in the disease
ecology of M. ulcerans [45,46]. These data and the presence of
M. ulcerans in possum faecal material from the same endemic
regions has led to the hypothesis that larval stages of mosquitoes
may and probably do ingest M. ulcerans as well as other bacteria via
filter feeding activity on decomposing, faecally contaminated
environments [47]. We mimicked this environment by establishing
simple aquatic microcosms, seeded with 1 or 2 instar Aedes
camptorhynchus larvae that were then transiently fed with possum
faecal material, spiked with either M. ulcerans-GFP or M. marinum-
GFP (Figure 4A). M. ulcerans and M. marinum were initially
liberated into the water from the food source but neither bacterial
species were detectable in water by week 4 (Figure 4B). Analysis of
4
th instar larvae at week 4 by fluorescence microscopy revealed an
accumulation of M. ulcerans primarily within the larval midgut and
around the mouthpart (Figure 4C). Fourth instar larvae assayed by
PCR for M. ulcerans had a mean bacterial load of 27,300615,200
cfu (n=4). The same pattern of accumulation within the insect
was not seen with M. marinum-GFP with very few fluorescent
bacteria observed in association with larvae (Figure 4C). Neither
M. ulcerans or M. marinum were detected in the microcosms
containing mosquito larvae only (Figure 4C). These data show that
mosquito larvae in contaminated aquatic environments were able
to ingest and maintain M. ulcerans within regions of the digestive
tract over a significant time period.
Table 1. Comparison of mycolactone promoter sequences with mycobacterial consensus sequences.
* Sequence
Promoter Species Gene 235 Spacer 210 Spacer +1 Reference/comments
SigA Mycobacteria Consensus TTGACW 17 TATAMT 6 G or A [38,40]
M. ulcerans mlsA1/mlsB TTGCAA 19 TAAATT 13 T Predicted by PoSSuM: P-value
1.875074e-04
M. ulcerans mlsA1/mlsB TTGCAA CCCATT
{ Mutagenesis of -10 box reduces
transcription
M. ulcerans mup045 TCGACT 16 TACAGC 3 G Predicted by PoSSuM: P-value
4.993513e-04
M. ulcerans mup045 TCGACT GGGCCC
{ Mutagenesis of -10 box reduces
transcription
SigD Mycobacteria Consensus GTANCGSS 16–20 NNANNN 1 G [40]
M. ulcerans mup053 GTATCGAC 17 ACAGGC 6 G Predicted by PoSSuM: P-value
8.445395e-05
M. ulcerans mup053 GTATCGAC GCCCGC
{ Mutagenesis of -10 box has no effect
*R denotes A or G, S denotes C or G, M denotes A or C, W denotes A or T as per IUB ambiguity codes, N denotes any A, T, G or C.
{Changed nucleotides shown in underline.
doi:10.1371/journal.pntd.0000553.t001
Figure 3. Histological study of serial mouse tail sections
following mouse-tail infection with M. ulcerans-GFP. (A) Fifty
days after subcutaneous inoculation in the tail of 10
5 bacilli showing the
beginning of ulceration. (B) Hematoxylin phloxine saffron staining on
tissue section reveals massive necrosis. (C) Ziehl-Nieelsen staining
showing many extracellular individual and clustered bacilli (arrowheads)
associated with necrosis, and (D) bacilli expressing GFP. Scale bars:
0.8 cm (A), 100 mm (B, C, and D) and 40 mm (C and D insets).
doi:10.1371/journal.pntd.0000553.g003
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In this study we have explored gene expression of six
pMUM001 genes required or implicated in mycolactone synthesis
and attempted to identify their transcriptional start sites and
promoter motifs.
Using a combination of primer extension and in silico analysis
together with a GFP reporter system, we were able to identify a
SigA-like promoter that drives expression of the mycolactone
polyketide megasynthases mlsA and mlsB in M. ulcerans. Primer
extension analyses with mRNA extracted from E. coli, M.
smegmatis and M. marinum bearing the GFP reporter construct
pJKD2893 and from wild-type M. ulcerans Agy99 all consistently
demonstrated a transcription start point (TSP) 533 bp upstream
of the mlsA1/mlsB initiation codons. The primer extension
analysis was fully supported by the GFP expression data, wherein
only strains containing expression constructs that spanned the
TSP at T533 produced fluorescence. These results indicate the
presence of a strong promoter preceding position T533.
Sequence scanning using PoSSuM of the region immediately
upstream of T533 for mycobacterial consensus promoter
sequences predicted a high probability SigA-like promoter
(Table 1). Site-directed mutagenesis of the putative 210 box by
substitution of three nucleotides completely abolished GFP
expression (Table 1, Figure 2B), implicating this sequence in
RNA polymerase (RNAP) binding. The mlsA/mlsB promoter lies
between two pseudogenes that once encoded transposases. These
CDS appear to be remnants of two distinct insertion sequence
elements (ISE) as the partial transposase sequences display
similarity to two different IS families (IS3 family for MUP034/
MUP042 and the IS6 family for MUP033/MUP041) [25]. These
vestigial ISE are quite distinct to the two high copy number
elements, IS2404 and IS2606 present in M. ulcerans. It is possible
that the T533 promoter was once a component of an ISE. A role
for ISE in altering gene expression in mycobacteria has been
reported [48]. Similarly, we investigated DNA sequences
upstream of mup045 and found a TSP at T207 with a potential
SigA promoter element predicted by PoSSuM and confirmed by
a loss of GFP expression in M. smegmatis following mutagenesis of
the proposed 210 box. The principal mycobacterial sigma factor
sigA is utilized by genes expressed during exponential growth
[49], thus the data from mlsA/B and mup045 fit well with our
previous report that show these genes are constantly expressed
during exponential growth in the heterologous host, M. marinum
[35].
PoSSuM sequence scanning predicted a SigA-like promoter
upstream of mup045, a finding confirmed by mutagenesis of its
putative 210 motif (Table 1). The same in silico search suggested a
SigD-like promoter element upstream of mup053. However,
mutation of the putative 210 motif for this gene resulted in no
significant difference in GFP production in either E. coli and
M. smegmatis backgrounds compared to wild type sequence,
Figure 4. Concentration of M. ulcerans-GFP within 4
th instar mosquito larvae. (A) Epifluorescence microscopy (x100 objective)
demonstrating that the majority of total fluorescent bacteria (DAPI-staining, blue filter) are also GFP-expressing M. ulcerans (JKD8083) and M.
marinum (JKD8062) (green filter). (B) Reduction of M. marinum and M. ulcerans within the water of the microcosms over the 4-week duration of the
experiment as measured by qPCR. Results are the means and standard deviations of four biological repeats. (C) Bright field, red fluorescence, green
fluorescence and composite images showing the accumulation of M. ulcerans around the mouth and mid-gut of a 4
th instar Aedes camptorhynchus
larva. Scale bar indicates 0.5 mm. Inset images are 6400 magnification. No specific green fluorescence was observed in larvae infected with M.
marinum or uninfected controls. Red fluorescence images were included to show that green fluorescence was due to GFP expression and not
autofluorescence.
doi:10.1371/journal.pntd.0000553.g004
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introduced mutations were not sufficiently different to the wild
type sequence to alter transcription. The latter scenario seems
more likely given the low complexity of SigD 210 consensus
sequences (Table 1).
The discovery in this study of the strong SigA-like promoter,
active in diverse bacterial genera, and driving expression of the
mycolactone mls PKS genes prompted us to transform M. ulcerans
with a reporter plasmid with GFP under the control of the T533
mls promoter, resulting in the highly green fluorescent strain M.
ulcerans JKD8049. M. ulcerans-GFP still produced mycolactone
and was capable of causing disease in a mouse-tail infection
model. Interestingly, GFP expression was more than 2-fold higher
in M. ulcerans than in M. marinum harbouring the same plasmid
(Figure 2A), suggesting additional regulatory factors might
augment mls expression in M. ulcerans (or conversely, repress
gene expression from the same promoter in other mycobacteria).
The high level of mls promoter activity and the presence of viable
M. ulcerans-GFP in the ulcerated tail tissue 50 days post
inoculation implies that there was sustained expression of the
mycolactone PKS and presumably sustained mycolactone
production by the bacteria within necrotic tissue (Figure 3).
These observations demonstrate the utility of this M. ulcerans-GFP
strain as a tool for following the dynamics of mls gene expression
during infection and understanding the role of mycolactone in
pathogenesis.
We also used M. ulcerans-GFP to explore the previously
reported association of M. ulcerans with Aedes camptorhynhcus
mosquitoes [45]. Here, we addressed the specific question of
whether or not A. camptorhynchus larvae could ingest M. ulcerans via
feeding on possum faecal material and whether the bacteria could
persist through the larval growth stages. Many larval mosquito
species filter feed on microbial particles and detritus where they
aggregate at air-water interfaces near plant stems and algal mats
in lentic waters [50,51] and a recent report has also suggested
that M. ulcerans can persist within the gut of Ochlerotatus triseriatus
mosquito larvae [52]. We were also able to observe the presence
of M. ulcerans within the gut contents of mosquito larvae in
laboratory experiments. However, the mode of larval ingestion
via possum faecal pellets that we have employed in this study,
presents a natural and viable pathway that A. camptorhynchus larvae
as well as other filter-feeding macroinvertebrates might become
infected for a long period of time with M. ulcerans. The peritrophic
matrix is a proteoglycan ‘sleeve’ that separates food sources from
the gut epithelium in insects [53] and our data suggests an
accumulation of M. ulcerans within this matrix through each instar
(Figure 4C). The significantly greater mean bacterial load of M.
ulcerans-GFP found in fourth instar larvae compared to M.
marinum-GFP may indicate that A. camptorhynchus larvae are able to
digest and assimilate M. marinum-GFP better than M. ulcerans or
that M. ulcerans is able to persist and perhaps multiply within the
peritrophic matrix. Production of GFP in the mosquito larvae
also indicates that the mycolactone mls genes are likely to be
expressed and producing mycolactone under these conditions.
Whether or not M. ulcerans can be transferred through larval,
pupal and then adult insects remains to be tested. Experiments
are now underway to examine vertical transmission of M. ulcerans
within mosquitoes.
The data presented in this study provide the first insights into
gene expression within the mycolactone biosynthesis locus and
the development of M. ulcerans-GFP, a strain where fluorescence
and toxin gene expression are linked thus providing a tool for
studying Buruli ulcer pathogenesis and potential transmission to
humans.
Supporting Information
Table S1 Bacterial strains and plasmids used in this study.
Found at: doi:10.1371/journal.pntd.0000553.s001 (0.09 MB
DOC)
Table S2 Oligonucleotides used in this study.
Found at: doi:10.1371/journal.pntd.0000553.s002 (0.07 MB
DOC)
Figure S1 Summary of fluorescence data demonstrating the
difference in promoter activity among strains containing GFP
reporter plasmid constructs. Shown are upstream regions from M.
ulcerans mup045 (A) and mup053 (B). Point mutations in putative
promoter region in the putative -10 motif of the mup045 promoter
region is marked by ‘X’. All values are expressed as fold changes
above the strain containing the empty vector pSM20. Strains are
identifiable by a two-letter prefix to the strain number EC - E. coli,
MS - M. smegmatis,M M-M. marinum and MU - M. ulcerans.
Found at: doi:10.1371/journal.pntd.0000553.s003 (0.19 MB
DOC)
Figure S2 Overview of the mls upstream region and primer
extension analysis. (A) Annotation of the sequence upstream of
mlsA1/mlsB showing the start position of the mls genes and the
putative mls TSP (indicated by ‘‘*’’) with predicted -10 and -35
promoter motifs assigned for each TSP (boxed). Representative
results are shown for fluorescent PE analysis performed on RNA
from (B) M. marinum 8062 and (C) M. ulcerans for mls using primer
PE-1. Primers PE-2 and PE-LM were used to cover the entire mls
upstream region (refer arrows in figure for primer binding
positions). PE analysis curves indicate the size (sz), height (ht)
and area under the curve (ar) of peaks consistently detected by
DNA fragment analysis.
Found at: doi:10.1371/journal.pntd.0000553.s004 (0.15 MB
DOC)
Figure S3 Overview of the mup045 and mup053 upstream
regions and primer extension analysis. (A) Annotation of the
sequence upstream of mup045 indicating the putative TSP
identified (indicated by ‘‘*’’) as well as putative -10 and -35
promoter sequences assigned by PoSSuM (boxed). The fluores-
cently labelled primer is also indicated (arrow) (B) PE analysis
graphs indicate the size (sz), height (ht) and area under the curve
(ar) of peaks consistently detected by DNA fragment analysis. (C)
Annotation of the sequence upstream of mup053 indicating the
putative TSP identified (indicated by ‘‘*’’) as well as putative -10
and -35 promoter sequences assigned by PoSSuM (boxed). The
fluorescently labelled primer is also indicated (arrow) (D) PE
analysis graphs indicate the size (sz), height (ht) and area under the
curve (ar) of peaks consistently detected by DNA fragment
analysis.
Found at: doi:10.1371/journal.pntd.0000553.s005 (0.15 MB
DOC)
Figure S4 Liquid chromatography-mass spectrometry analysis
of acetone soluble lipid extracts from M. ulcerans-GFP. Indicated is
the presence of mycolactone A/B ([M+Na]+ at m/z 765.5) and the
presence of the nonhydroxylated mycolactone ([M+Na]+ at m/z
749.5). (A) Ion trace for m/z 765.5; (B) ion trace for m/z 749.5.
Found at: doi:10.1371/journal.pntd.0000553.s006 (0.10 MB
DOC)
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